drugset / Trial / NCT05742841
EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)
NaSingle-groupOpen-labelPrevention
Summary
The EMERALD intervention involves 1) ordering an Emergency Department (ED) lipid panel, 2) calculating 10-year Atherosclerotic cardiovascular disease (ASCVD) risk using the Pooled Cohort Equations, 3) prescribing a moderate- or high-intensity statin if applicable, and 4) referring patients to outpatient care (primary care, preventive cardiology, or general cardiology, depending on risk level).
Timeline
- Start
- 2023-03-08
- Primary completion
- 2023-06-01
- Completion
- 2023-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 10 mg | — |
| Subject | Rosuvastatin | Small molecule | 40 mg | — |